Viloxazine, a Non-stimulant Norepinephrine Reuptake Inhibitor, for the Treatment of Attention Deficit Hyperactivity Disorder: A 3 Year Update.

Haddad, Hannah W; Hankey, Paul B; Ko, Jimin; Eswani, Zahaan; Bhatti, Pravjit; Edinoff, Amber N; Kaye, Adam M; Kaye, Alan D.

Afiliação

Haddad HW; Kansas City University.
Hankey PB; Kansas City University.
Ko J; Georgetown University.
Eswani Z; Louisiana State University Health Science Center Shreveport.
Bhatti P; Georgetown University.
Edinoff AN; Psychiatry and Behavioral Medicine, Louisiana State University Health Science Center Shreveport.
Kaye AM; Thomas J. Long School of Pharmacy and Health Sciences.
Kaye AD; Anesthesiology, Louisiana State University Health Science Center Shreveport.

Health Psychol Res ; 10(3): 37018, 2022.

Article em En | MEDLINE | ID: mdl-35910243